Cargando…
Inhibition of galectins in cancer: Biological challenges for their clinical application
Galectins play relevant roles in tumor development, progression and metastasis. Accordingly, galectins are certainly enticing targets for medical intervention in cancer. To date, however, clinical trials based on galectin inhibitors reported inconclusive results. This review summarizes the galectin...
Autores principales: | Laderach, Diego José, Compagno, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872792/ https://www.ncbi.nlm.nih.gov/pubmed/36703969 http://dx.doi.org/10.3389/fimmu.2022.1104625 |
Ejemplares similares
-
Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity
por: Corapi, Enrique, et al.
Publicado: (2018) -
Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure
por: Laderach, Diego José, et al.
Publicado: (2021) -
Galectins as Checkpoints of the Immune System in Cancers, Their Clinical Relevance, and Implication in Clinical Trials
por: Compagno, Daniel, et al.
Publicado: (2020) -
Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome
por: Tiraboschi, Carolina, et al.
Publicado: (2020) -
Galectins as New Prognostic Markers and Potential Therapeutic Targets for Advanced Prostate Cancers
por: Laderach, Diego J., et al.
Publicado: (2013)